If the paper is based on the analysis of sequence data, it's almost certainly been processed by closed or "shared source" primary data analysis tools. That's tr

If the paper is based on the analysis of sequence data, it's almost certainly been processed by closed or "shared source" primary data analysis tools. That's true of Illumina/Roche/ABI. Biotech vendors have quite a long way to go in this regard.